Edwards Lifesciences Corp
EW
105.80−0.01 (−0.01%)Nov 12, 7:00 PM ET
Key stats
- Open
- 106.07
- Day high
- 106.80
- Day low
- 104.93
- Previous close
- 105.81
- Volume
- 4.18M
- VWAP
- 105.82
- 52-week high
- 106.80
- 52-week low
- 74.66
- Market cap
- 60.84B
- Shares out
- 575.00M
- Employees
- 16,000
- Listed
- 2000
About Edwards Lifesciences Corp
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · IRVINE, CA · edwards.com
Options · expiring Nov 20
Nov 12, 3:59 PM ET- Call open interest
- 19.7K
- Put open interest
- 4.8K
- Put/call
- 0.24
- At-the-money IV
- 28.8%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 87.50 call | 13.53 | Nov 6, 11:30 AM | 60 | 190 | 64.0% |
| 90 call | 15.83 | Nov 12, 3:22 PM | 43 | 2.8K | 78.4% |
| 95 call | 11.15 | Nov 11, 3:57 PM | 33 | 2.3K | 53.0% |
| 115 call | 0.11 | Nov 11, 3:20 PM | 33 | 166 | 40.0% |
| 85 call | 17.45 | Nov 6, 12:27 PM | 20 | 95 | 83.7% |
| 110 call | 0.30 | Nov 12, 2:15 PM | 15 | 3.3K | 25.5% |
Quarterly results
Massive · Nov 4, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $1.72B | $1.74B | $1.65B | $1.57B |
| Gross profit | $1.35B | $1.35B | $1.29B | $1.23B |
| Operating income | $299.10M | $513.20M | $477.60M | $96.80M |
| Net income | $307.50M | $241.90M | $380.70M | $91.20M |
| Diluted EPS | 0.53 | 0.42 | 0.66 | 0.16 |
| Operating cash flow | $570.30M | $651.90M | $43.80M | $450.90M |
| Assets | $14.14B | $13.87B | $13.32B | $13.70B |
| Liabilities | $3.18B | $3.14B | $2.99B | $3.36B |
| Equity | $10.96B | $10.72B | $10.33B | $10.34B |
Technicals
Massive · Nov 12, 2026- 50-day average90.08
- 200-day average86.21
- RSI (14 days)78.8
Short interest
Massive · Oct 30, 2026- Oct 30, 20269.38M shares · 2.8 days to cover
- Oct 15, 20269.33M shares · 2.5 days to cover
- Sep 30, 20269.54M shares · 2.5 days to cover
- Sep 15, 20269.09M shares · 3.1 days to cover
Splits
Massive · Jun 1, 2020- Jun 1, 20203-for-1
- Dec 14, 20152-for-1
- May 28, 20102-for-1
Related companies
MassiveNews coverage
No stories about Edwards Lifesciences Corp right now.